Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice
We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis f...
Gespeichert in:
Veröffentlicht in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2016-08, Vol.68 (2), p.411-417 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 417 |
---|---|
container_issue | 2 |
container_start_page | 411 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 68 |
creator | Chalouhi, Nohra Starke, Robert M Correa, Tatiana Jabbour, Pascal M Zanaty, Mario Brown, Robert D Torner, James C Hasan, David M |
description | We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin. |
doi_str_mv | 10.1161/HYPERTENSIONAHA.116.07515 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4945417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27296993</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</originalsourceid><addsrcrecordid>eNqNUNtu1DAQtRCILi2_gMwHpPie-AGkqN2ylUpbbVsET5bjTLqGbBLZCaV_j8NCVXhAWGON5nLOzByEXlNySKmib1afL5fr6-X51enFebkq5-QhySWVT9CCSiYyIRV_ihaEapFpSj_toRcxfiGECiHy52iP5UwrrfkCfTz2TQMButHbFl_Bd7yGOPRdBDz2uIyDD77DyY7BBbDRd7e47GAK93GL19MwTgHm8mra2i5i29X4g3dwgJ41to3w8pffRzcny-ujVXZ28f70qDzLnCRcZqBkVWvCK90URdqjcBS4ZMxqXuRaVoJJxp12SjlVF07l0ilNVK5rIUVd5XwfvdvxDlO1hdqlO4JtzRD81oZ701tv_qx0fmNu-29G6MRAZwK9I3ChjzFA84ClxMxim7_EnpPmp9gJ--rx8Afkb3VTw9tdw13fjhDi13a6g2A2YNtx818DxD_wJD3BVJExQhUpUpSlzyT_AeWzobE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Chalouhi, Nohra ; Starke, Robert M ; Correa, Tatiana ; Jabbour, Pascal M ; Zanaty, Mario ; Brown, Robert D ; Torner, James C ; Hasan, David M</creator><creatorcontrib>Chalouhi, Nohra ; Starke, Robert M ; Correa, Tatiana ; Jabbour, Pascal M ; Zanaty, Mario ; Brown, Robert D ; Torner, James C ; Hasan, David M</creatorcontrib><description>We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.116.07515</identifier><identifier>PMID: 27296993</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject><![CDATA[Aneurysm, Ruptured - metabolism ; Aneurysm, Ruptured - pathology ; Aneurysm, Ruptured - prevention & control ; Animals ; Aspirin - administration & dosage ; Aspirin - pharmacokinetics ; Cerebral Arteries - metabolism ; Cerebral Arteries - pathology ; Cyclooxygenase 2 - metabolism ; Cyclooxygenase Inhibitors - administration & dosage ; Cyclooxygenase Inhibitors - pharmacokinetics ; Disease Models, Animal ; Female ; Follow-Up Studies ; Humans ; Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors ; Hydroxyprostaglandin Dehydrogenases - metabolism ; Incidence ; Intracranial Aneurysm - metabolism ; Intracranial Aneurysm - pathology ; Intracranial Aneurysm - prevention & control ; Male ; Mice ; Risk Factors ; Sex Factors ; Subarachnoid Hemorrhage - etiology ; Subarachnoid Hemorrhage - prevention & control]]></subject><ispartof>Hypertension (Dallas, Tex. 1979), 2016-08, Vol.68 (2), p.411-417</ispartof><rights>2016 American Heart Association, Inc</rights><rights>2016 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</citedby><cites>FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27296993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chalouhi, Nohra</creatorcontrib><creatorcontrib>Starke, Robert M</creatorcontrib><creatorcontrib>Correa, Tatiana</creatorcontrib><creatorcontrib>Jabbour, Pascal M</creatorcontrib><creatorcontrib>Zanaty, Mario</creatorcontrib><creatorcontrib>Brown, Robert D</creatorcontrib><creatorcontrib>Torner, James C</creatorcontrib><creatorcontrib>Hasan, David M</creatorcontrib><title>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.</description><subject>Aneurysm, Ruptured - metabolism</subject><subject>Aneurysm, Ruptured - pathology</subject><subject>Aneurysm, Ruptured - prevention & control</subject><subject>Animals</subject><subject>Aspirin - administration & dosage</subject><subject>Aspirin - pharmacokinetics</subject><subject>Cerebral Arteries - metabolism</subject><subject>Cerebral Arteries - pathology</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Cyclooxygenase Inhibitors - administration & dosage</subject><subject>Cyclooxygenase Inhibitors - pharmacokinetics</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors</subject><subject>Hydroxyprostaglandin Dehydrogenases - metabolism</subject><subject>Incidence</subject><subject>Intracranial Aneurysm - metabolism</subject><subject>Intracranial Aneurysm - pathology</subject><subject>Intracranial Aneurysm - prevention & control</subject><subject>Male</subject><subject>Mice</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Subarachnoid Hemorrhage - etiology</subject><subject>Subarachnoid Hemorrhage - prevention & control</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUNtu1DAQtRCILi2_gMwHpPie-AGkqN2ylUpbbVsET5bjTLqGbBLZCaV_j8NCVXhAWGON5nLOzByEXlNySKmib1afL5fr6-X51enFebkq5-QhySWVT9CCSiYyIRV_ihaEapFpSj_toRcxfiGECiHy52iP5UwrrfkCfTz2TQMButHbFl_Bd7yGOPRdBDz2uIyDD77DyY7BBbDRd7e47GAK93GL19MwTgHm8mra2i5i29X4g3dwgJ41to3w8pffRzcny-ujVXZ28f70qDzLnCRcZqBkVWvCK90URdqjcBS4ZMxqXuRaVoJJxp12SjlVF07l0ilNVK5rIUVd5XwfvdvxDlO1hdqlO4JtzRD81oZ701tv_qx0fmNu-29G6MRAZwK9I3ChjzFA84ClxMxim7_EnpPmp9gJ--rx8Afkb3VTw9tdw13fjhDi13a6g2A2YNtx818DxD_wJD3BVJExQhUpUpSlzyT_AeWzobE</recordid><startdate>201608</startdate><enddate>201608</enddate><creator>Chalouhi, Nohra</creator><creator>Starke, Robert M</creator><creator>Correa, Tatiana</creator><creator>Jabbour, Pascal M</creator><creator>Zanaty, Mario</creator><creator>Brown, Robert D</creator><creator>Torner, James C</creator><creator>Hasan, David M</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201608</creationdate><title>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</title><author>Chalouhi, Nohra ; Starke, Robert M ; Correa, Tatiana ; Jabbour, Pascal M ; Zanaty, Mario ; Brown, Robert D ; Torner, James C ; Hasan, David M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aneurysm, Ruptured - metabolism</topic><topic>Aneurysm, Ruptured - pathology</topic><topic>Aneurysm, Ruptured - prevention & control</topic><topic>Animals</topic><topic>Aspirin - administration & dosage</topic><topic>Aspirin - pharmacokinetics</topic><topic>Cerebral Arteries - metabolism</topic><topic>Cerebral Arteries - pathology</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Cyclooxygenase Inhibitors - administration & dosage</topic><topic>Cyclooxygenase Inhibitors - pharmacokinetics</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors</topic><topic>Hydroxyprostaglandin Dehydrogenases - metabolism</topic><topic>Incidence</topic><topic>Intracranial Aneurysm - metabolism</topic><topic>Intracranial Aneurysm - pathology</topic><topic>Intracranial Aneurysm - prevention & control</topic><topic>Male</topic><topic>Mice</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Subarachnoid Hemorrhage - etiology</topic><topic>Subarachnoid Hemorrhage - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chalouhi, Nohra</creatorcontrib><creatorcontrib>Starke, Robert M</creatorcontrib><creatorcontrib>Correa, Tatiana</creatorcontrib><creatorcontrib>Jabbour, Pascal M</creatorcontrib><creatorcontrib>Zanaty, Mario</creatorcontrib><creatorcontrib>Brown, Robert D</creatorcontrib><creatorcontrib>Torner, James C</creatorcontrib><creatorcontrib>Hasan, David M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chalouhi, Nohra</au><au>Starke, Robert M</au><au>Correa, Tatiana</au><au>Jabbour, Pascal M</au><au>Zanaty, Mario</au><au>Brown, Robert D</au><au>Torner, James C</au><au>Hasan, David M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2016-08</date><risdate>2016</risdate><volume>68</volume><issue>2</issue><spage>411</spage><epage>417</epage><pages>411-417</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><abstract>We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>27296993</pmid><doi>10.1161/HYPERTENSIONAHA.116.07515</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2016-08, Vol.68 (2), p.411-417 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4945417 |
source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Aneurysm, Ruptured - metabolism Aneurysm, Ruptured - pathology Aneurysm, Ruptured - prevention & control Animals Aspirin - administration & dosage Aspirin - pharmacokinetics Cerebral Arteries - metabolism Cerebral Arteries - pathology Cyclooxygenase 2 - metabolism Cyclooxygenase Inhibitors - administration & dosage Cyclooxygenase Inhibitors - pharmacokinetics Disease Models, Animal Female Follow-Up Studies Humans Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors Hydroxyprostaglandin Dehydrogenases - metabolism Incidence Intracranial Aneurysm - metabolism Intracranial Aneurysm - pathology Intracranial Aneurysm - prevention & control Male Mice Risk Factors Sex Factors Subarachnoid Hemorrhage - etiology Subarachnoid Hemorrhage - prevention & control |
title | Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T00%3A08%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Sex%20Response%20to%20Aspirin%20in%20Decreasing%20Aneurysm%20Rupture%20in%20Humans%20and%20Mice&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Chalouhi,%20Nohra&rft.date=2016-08&rft.volume=68&rft.issue=2&rft.spage=411&rft.epage=417&rft.pages=411-417&rft.issn=0194-911X&rft.eissn=1524-4563&rft_id=info:doi/10.1161/HYPERTENSIONAHA.116.07515&rft_dat=%3Cpubmed_cross%3E27296993%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27296993&rfr_iscdi=true |